newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) ("NovaBay" or the "Company") announces it has entered into a definitive asset purchase agreement (the "Agreement") with PRN Physician Recommended Nutriceuticals, LLC